| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Ecor1 Capital Fund Qualified, L.P. is a 10% Owner at KURA, with reported holdings spanning 2 companies. Recent filings cover 10 purchases and 8 sales. Those positions are worth an estimated $58.0M at current prices.
Ecor1 Capital Fund Qualified, L.P.'s largest disclosed position is in KURA as 10% Owner, worth about $58.0M. Net of sales, the recent Form 4 record there shows accumulation of 347,812 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2018 | KURA Kura Oncology, Inc. | 10% Owner | Buy | 213,888 | $13.57 | $2,901,833.34 | +5.1% | |
| Dec 17, 2018 | KURA Kura Oncology, Inc. | 10% Owner | Sell | 26,520 | $13.20 | $350,064.00 | -0.6% | |
| Dec 13, 2018 | KURA Kura Oncology, Inc. | 10% Owner | Buy | 40,538 | $13.90 | $563,362.39 | +1.0% | |
| Dec 6, 2018 | KURA Kura Oncology, Inc. | 10% Owner | Buy | 119,906 | $13.50 | $1,618,254.85 | +3.0% | |
| May 16, 2018 | ATYR Atyr Pharma Inc | 10% Owner | Sell | 3,209,316 | $0.93 | $2,999,055.65 | -100% | |
| Nov 13, 2017 | ATYR Atyr Pharma Inc | 10% Owner | Sell | 13,832 | $4.08 | $56,474.72 | -0.4% | |
| Nov 1, 2017 | ATYR Atyr Pharma Inc | 10% Owner | Buy | 29,607 | $4.84 | $143,333.35 | +0.9% |